Sichuan Kelun Pharmaceutical Co., Ltd. (SHE:002422)

Market Cap	62.60B
Revenue (ttm)	19.98B
Net Income (ttm)	2.49B
Shares Out	1.59B
EPS (ttm)	1.57
PE Ratio	25.09
Forward PE	17.93
Dividend	1.01 (2.64%)
Ex-Dividend Date	Oct 23, 2024

Volume	23,181,906
Average Volume	20,902,414
Open	35.00
Previous Close	38.07
Day's Range	35.00 - 40.80
52-Week Range	25.72 - 40.13
Beta	-0.02
RSI	70.53
Earnings Date	Apr 24, 2025

About SHE:002422

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, manufactures, distributes, and sells pharmaceutical products in China. It offers infusion products; oral medication and other dosage form; plastic ampoule and powder liquid dual chamber infusion bag; medical devices, such as infusion set, injection syringes, detained needles, nebulizer, and blood sampling; and over-the-counter products. The company was founded in 1996 and is based in Chengdu, the People's Republic of China. Sichuan Kelun Pharmaceutical Co., Ltd. is a subsidiary of Sic...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1996
• Employees: 21,864
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002422

Financial Performance

In 2024, SHE:002422's revenue was 21.81 billion, an increase of 1.67% compared to the previous year's 21.45 billion. Earnings were 2.94 billion, an increase of 19.53%.